Skip to main content
Caplight Logo









Ruilaipu (Hangzhou) Medical Technology Co., Ltd.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd.

Private
HangzhouHealthcare & Life Scienceshttp://ruilaipu.com/

Last Round

Series B

Sep 26, 2024

Total Funding Raised

$14.4M

Company Overview

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is a medical technology company that develops high-performance liquid chromatography tandem mass spectrometry (HPLC-MS/MS) detection systems and automated sample pretreatment platforms for clinical diagnostics.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Biotech Equipment, Precision Medicine

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Keywords

mass spectrometryHPLC-MS/MSlaboratory automationclinical diagnosticssample pretreatmentmedical instrumentationprecision medicinemass speclab automationinorganic mass spectrometerclinical lab equipmentanalytical chemistrydiagnostic hardwarebiotech equipment

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Comparables

Compare Ruilaipu (Hangzhou) Medical Technology Co., Ltd. with similar companies based on industry and business-model similarity.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Shanghai Reigncom Biotech Co., Ltd.
89%
Hangzhou Calibra Diagnostics Co., Ltd.
87%
Hangzhou Well-healthcare Technologies Co., Ltd.
87%

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BSep 26, 2024
Series A ExtensionFeb 6, 2023
Series A ExtensionMar 31, 2022
Series A ExtensionMay 31, 2021
Series ADec 18, 2020
Angel
Oct 1, 2019

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Investors

Notable investors and investment history

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. investors
InvestorRounds
3H Health InvestmentSeries A Extension
Legend CapitalSeries A Extension, Series A
Guangzhou Industrial Investment Holding GroupSeries B
辰德资本Series A Extension, Series B, Series A, Angel
Vinno CapitalSeries B
Huagai CapitalSeries A, Series A Extension
CPESeries A Extension

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 31, 2021

    Led by 3H Health Investment with participation from Huagai Capital, Legend Capital, and 辰德资本.

  • Dec 18, 2020

    Raised Series A with Huagai Capital, Legend Capital, and 辰德资本.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. Filings

Explore SEC and related filing metadata, where available.

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s valuation, stock price, and market status.

Is Ruilaipu (Hangzhou) Medical Technology Co., Ltd. a public or private company?

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is a private company.

What is the current stock price of Ruilaipu (Hangzhou) Medical Technology Co., Ltd.?

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.

How much is Ruilaipu (Hangzhou) Medical Technology Co., Ltd. worth (valuation)?

Valuation information for Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is not publicly available.

Can I buy Ruilaipu (Hangzhou) Medical Technology Co., Ltd. stock?

Ruilaipu (Hangzhou) Medical Technology Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s last funding round?

Funding round information for Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is not publicly available.

Who are the main investors in Ruilaipu (Hangzhou) Medical Technology Co., Ltd.?

Investor information for Ruilaipu (Hangzhou) Medical Technology Co., Ltd. is not publicly disclosed.

Will Ruilaipu (Hangzhou) Medical Technology Co., Ltd. IPO soon?

No public IPO plans have been announced for Ruilaipu (Hangzhou) Medical Technology Co., Ltd..

How can I track Ruilaipu (Hangzhou) Medical Technology Co., Ltd. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ruilaipu (Hangzhou) Medical Technology Co., Ltd.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersHangzhou
Year Founded2019
Last FundingSep 26, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?